TipRanks
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft Unsponsored ADR (DE:MUVB)
FRANKFURT:MUVB
Germany Market
EarningsQ2 2026 Earnings Report

Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft Unsponsored ADR (MUVB) Q2 2026 Earnings Report

3 Followers

DE:MUVB Q2 2026 EPS Results

Actual EPS€0.36
Consensus EPS€0.29
Beat/MissBeat by +€0.07
One Year Ago EPS€0.33

DE:MUVB Q2 2026 Revenue Results

Actual Revenue€19.35B
Expected Revenue€16.73B
Beat/MissBeat by +€2.62B
YoY Revenue Growth+9.13%

Earnings Announcement Details

QuarterQ2 2026
Date08/07/2026
TimeBefore Open
Conference CallFriday, August 7, 2026
DE:MUVB Upcoming Earnings
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft Unsponsored ADR's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:MUVB Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 07, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a strong set of operating and financial metrics (robust net income, 23% ROE, solid investment returns, Life Re and ERGO momentum, and a very strong solvency position) that underline the company’s resilience and diversified earnings profile. However, notable challenges remain in P&C reinsurance: top-line softening (EUR 2bn guidance cut), July renewals showing volume (-9%) and price (-5.5%) pressure, and a rising normalized combined ratio (~82% and expected to trend up) partly driven by a large structured transaction. Management emphasizes disciplined underwriting, capital strength, and the ability to redeploy capacity, and remains confident on full-year earnings targets despite near-term top-line and mix headwinds.
Company Guidance
Munich Re updated its outlook while keeping Ambition 2030 intact: H1 net result was EUR 3.9bn (over 60% of full‑year guidance) and Q2 net profit EUR 2.2bn, with ROE at 23% (vs Ambition target >18%) and Solvency II ~304%; reinsurance revenue guidance was cut by EUR 2bn to EUR 38bn (P&C Re H1 revenue down ~EUR 1.4bn, ~1/3 FX/NDIC), July renewals saw volumes -9% with prices -5.5% and a ~1ppt negative mix, P&C Re Q2 reported combined ratio 68.9% (normalized ~82% and expected to trend up) with reserve releases of ~6pp, and the large structured deal is earning through into 2027; Life & Health Re posted a Q2 total technical result of EUR 528m and H1 >EUR 1bn with CSM stock EUR 16bn; GSI has grown ~EUR 800m p.a. through 2024 with Q2 combined ratio 88.9% (H1 86.3%) and organic growth toward the 5–9% Ambition range; ERGO Q2 net result EUR 321m (Germany EUR 235m, International EUR 86m) and insurance revenue guidance remains EUR 24bn; investment ROI was 5.5% in Q2 (4.2% for H1), running yield 4.0% and reinvestment yield 4.3%; management reiterates targets of ROE >18% and >8% average annual EPS growth and remains committed to dividends and buybacks.
Strong first-half profitability
Net result of EUR 3.9 billion in H1 2026 (already >60% of full-year net income guidance) and a strong Q2 net profit of EUR 2.2 billion, demonstrating robust near-term earnings delivery.
High return on equity
Return on equity of 23% for the first half, comfortably above the Ambition 2030 target of >18%.
Robust investment performance
Investment return in Q2 of 5.5%, running yield of 4.0% and reinvestment yield of 4.3%; six-month ROI of 4.2%, comfortably within full-year guidance (>3.5%).
Very strong solvency position
Economic solvency (Solvency II) ratio increased to 304%, providing substantial capital flexibility for underwriting and shareholder returns.
Life & Health reinsurance momentum
Life & Health reinsurance delivered a total technical result of EUR 528 million in Q2 and >EUR 1 billion in H1; CSM stock reached EUR 16 billion and management highlighted continued transactional pipeline (including longevity and structured deals).
ERGO delivering reliable earnings
ERGO net result of EUR 321 million in the quarter (ERGO Germany EUR 235 million); strong technical profitability and international growth (ERGO International net result EUR 86 million).
Global Specialty Insurance (GSI) resilience
GSI combined ratios consistently around 90% historically; H1 combined ratio 86.3% with Q2 at 88.9%; organic growth (FX-adjusted) remained positive and the segment is on track for Ambition 2030 targets.
Diversified earnings mix and disciplined underwriting
Management emphasized diversified contributions (GSI, Life Re, ERGO offsetting P&C Re headwinds), ability to walk away from unprofitable business, and disciplined July renewals execution.

DE:MUVB Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 12, 2026
2026 (Q3)
0.22 / -
0.32―
2026 (Q2)
0.29 / 0.36
0.3328.60% (+0.03)
2026 (Q1)
0.29 / 0.27
0.17160.42% (+0.10)
2025 (Q4)
0.15 / 0.15
0.1446.21% (<+0.01)
2025 (Q3)
0.30 / 0.32
0.13145.89% (+0.19)
2025 (Q2)
0.28 / 0.33
0.23740.38% (+0.10)
2025 (Q1)
0.16 / 0.17
0.311-44.83% (-0.14)
2024 (Q4)
0.11 / 0.14
0.1440.00% (0.00)
2024 (Q3)
0.17 / 0.13
0.164-20.65% (-0.03)
2024 (Q2)
0.21 / 0.24
0.16642.47% (+0.07)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed